Esperion Therapeutics, Inc.
USD3.15
-0.02 (-0.63%)
CEO
Sheldon L. Koenig
IPO Date
2013-06-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.17
Prev. Close
$3.17
Day Low
$3.15
Day High
$3.17
52W Low
$0.95
52W High
$4.18
Market Cap
$0.65B
Volume
5.72M
| -8.0 |
| 31 Dec 2023 | FY | 62.8% | -179.9% | 46.0% | -101.7% | -1.19 | 1.29 | -1.5 |
| 31 Dec 2022 | FY | 64.3% | -309.6% | 72.2% | -94.2% | -0.81 | 2.67 | -1.8 |
| 31 Dec 2021 | FY | 81.9% | -343.0% | 136.6% | -70.5% | -1.32 | 4.48 | -0.5 |
| 31 Dec 2020 | FY | 98.9% | -63.1% | 149.3% | -40.6% | -1.93 | 3.68 | -5.0 |
| 31 Dec 2019 | FY | 100.0% | -65.5% | -487.0% | -45.3% | 0.08 | 3.20 | -16.6 |
| 31 Dec 2018 | FY | 99.9% | -109.4% | 33.7% | -140.7% | 0.00 | 2.22 | -6.1 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -68.2% | -60.1% | 0.00 | 6.15 | -9.4 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -32.8% | -30.6% | 0.01 | 13.70 | -3.8 |
| 3.5 |
| 30 Sept 2025 | Q3 | 36.5% | -35.9% | 6.9% | -8.6% | -1.33 | 1.00 | -4.2 |
| 30 Jun 2025 | Q2 | 65.4% | -15.4% | 2.9% | -3.7% | -1.38 | 1.15 | -3.8 |
| 31 Mar 2025 | Q1 | 51.5% | -62.2% | 9.5% | -12.5% | -0.70 | 1.18 | -1.7 |
| 31 Dec 2024 | Q4 | 62.9% | -30.8% | 5.5% | -6.2% | -0.77 | 1.37 | -5.0 |
| 30 Sept 2024 | Q3 | 66.5% | -57.2% | 8.0% | -9.4% | -0.73 | 1.85 | -2.7 |
| 30 Jun 2024 | Q2 | 78.9% | -83.9% | 18.0% | -17.6% | -0.78 | 1.97 | -1.8 |
| 31 Mar 2024 | Q1 | 92.7% | 44.3% | -20.7% | 16.4% | -1.87 | 2.22 | 1.9 |
| 31 Dec 2023 | Q4 | 64.5% | -174.7% | 12.4% | -27.4% | -1.19 | 1.29 | -1.5 |